USPTO Examiner PORTER RACHEL L - Art Unit 3684

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18403887SYSTEM AND METHOD FOR DIGITAL THERAPEUTICS IMPLEMENTING A DIGITAL DEEP LAYER PATIENT PROFILEJanuary 2024November 2025Abandon2311NoNo
18545241Fitness Watch Configured with Micro AIDecember 2023February 2025Allow1410NoNo
18286750METHOD, APPARATUS RELATED TO MEDICATION LIST MANAGEMENT, AND COMPUTER-READABLE RECORDING MEDIUMOctober 2023April 2025Abandon1810NoNo
18552378DIAGNOSIS PREDICTION SYSTEM USING DIGITAL DEVICE, LEARNING DEVICE, COMPUTER PROGRAM, DIAGNOSIS PREDICTION METHOD, AND PREDICTION MODEL GENERATION/UPDATING METHODSeptember 2023September 2025Abandon2410NoNo
18473009SYSTEM AND METHOD FOR DETERMINING SUBJECT CONDITIONS IN MOBILE HEALTH CLINICAL TRIALSSeptember 2023January 2025Allow1610YesNo
18240474Method for Operating a System that Identifies a User's Eating Habits, Recommends Food, and Provides a Food ReportAugust 2023August 2025Abandon2310NoNo
18228662STANDARDIZED PATIENT-PROVIDED DATA AND INTERVENTIONS BASED ON SIGNIFICANCE CODESJuly 2023September 2025Abandon2601NoNo
18356344DETERMINING A GENETIC PREDISPOSITION OF A MEDICAL CAUSEJuly 2023March 2026Abandon3120YesNo
17907644ANIMAL CARE SUPPORT SYSTEM, ANIMAL CARE SUPPORT SERVER, AND ANIMAL CARE SUPPORT PROGRAMApril 2023August 2025Abandon3410NoNo
18090168PERSONALIZED THERAPY DELIVERY VIA ASSESSMENT TRACKINGDecember 2022October 2025Abandon3440YesNo
17901349SYSTEMS AND METHODS FOR PROVIDING DIGITAL HEALTHCARE SERVICESSeptember 2022November 2025Abandon3820YesNo
17875819SYSTEMS AND METHODS FOR USING MACHINE LEARNING WITH EPIDEMIOLOGICAL MODELINGJuly 2022December 2024Abandon2910NoNo
17845380MANAGED MEDICAL INFORMATION EXCHANGEJune 2022February 2026Allow4450NoNo
17831772MACHINE-LEARNING TECHNIQUES FOR GENERATING ENTITY INSTRUCTIONSJune 2022April 2025Abandon3451YesNo
17709349MACHINE LEARNING DRIVEN AUTOMATED DESIGN OF CLINICAL STUDIES AND ASSESSMENT OF PHARMACEUTICALS AND MEDICAL DEVICESMarch 2022April 2025Abandon3610NoNo
17695007CUSTOMIZED SKIN CARE METHOD AND SYSTEMMarch 2022August 2025Abandon4120NoNo
17694022TEST SERVER, COMMUNICATION TERMINAL, TEST SYSTEM, AND TEST METHODMarch 2022October 2024Abandon3240NoNo
17639892INFORMATION PRESENTATION DEVICE, LEARNING DEVICE, INFORMATION PRESENTATION METHOD, LEARNING METHOD, INFORMATION PRESENTATION PROGRAM, AND LEARNING PROGRAMMarch 2022September 2025Abandon4320NoNo
17621837SYSTEMS AND METHODS FOR DETERMINING NEONATAL MORTALITY IN ANIMALSDecember 2021March 2025Abandon3820YesNo
17552839SYSTEM AND METHOD FOR DETERMINING TESTING AND TREATMENTDecember 2021May 2025Abandon4120NoNo
17457403INGESTING AND PROCESSING CLINICAL INFORMATION BY A CLINICAL ENGINEDecember 2021January 2025Abandon3720NoNo
17541004APPARATUSES, SYSTEMS, AND METHODS FOR DETERMINING HEALTHCARE VITALITYDecember 2021March 2025Abandon4020NoNo
17531839SYSTEM AND METHOD FOR CLINICAL TRIALSNovember 2021September 2025Abandon4630YesNo
17520502MEDICAL DEVICE WITH DOSE HELPER FUNCTIONALITY INCLUDING TIME ZONE OR LOCATION DETERMINATIONNovember 2021April 2025Allow4240YesNo
17503037METHOD AND SYSTEM FOR DYNAMICALLY GENERATING CULTURALLY SENSITIVE PROFILE-SPECIFIC THERAPEUTIC PROTOCOLS USING MACHINE LEARNING MODELSOctober 2021July 2025Abandon4511NoNo
17469835Pan-Indication Gradient Boosting Model Using Tumor Kinetics for Survival PredictionSeptember 2021February 2025Abandon4220YesNo
17459998TELEHEALTH AND MICRODOSING PLATFORM FOR PSYCHEDELIC-ASSISTED THERAPYAugust 2021October 2024Abandon3710NoNo
17367420MEDICATION RISK EVALUATION METHOD AND MEDICATION RISK EVALUATION DEVICEJuly 2021October 2025Abandon5260YesNo
17335358MONITORING A HEALTH CARE PROFESSIONAL MOVEMENT RELATIVE TO A VIRTUAL BOUNDARY IN AN OPERATING ROOMJune 2021October 2025Abandon5240NoNo
17335362CONTROL ACCESS VERIFICATION OF A HEALTH CARE PROFESSIONALJune 2021October 2025Abandon5340NoNo
17332485Adapting Computer Modeling of Infectious Disease Based on Noisy DataMay 2021May 2025Abandon4840NoNo
17291401Computation Model of Learning NetworksMay 2021August 2025Abandon5140YesNo
17284176AUTOMATED TECHNIQUES FOR TESTING PROSPECTIVE MEMORYApril 2021April 2025Abandon4830NoNo
17218316RECOVERY PROFILE CLUSTERING TO DETERMINE TREATMENT PROTOCOL AND PREDICT RESOURCING NEEDSMarch 2021October 2025Abandon5540NoNo
17217738DEFIBRILLATOR INCIDENT REPORTING AND DEFIBRILLATOR/EPCR INTEGRATIONMarch 2021March 2025Allow4821YesNo
17213730MEDICAL SYSTEM, NETWORK APPARATUS, MEDICAL APPARATUS, AND INSPECTION INFORMATION PROCESSING METHODMarch 2021January 2025Abandon4520YesNo
17249819UTILIZING MACHINE LEARNING AND NATURAL LANGUAGE PROCESSING TO EXTRACT AND VERIFY VACCINATION DATAMarch 2021September 2025Abandon5540YesNo
17255002METHOD FOR DRUG RECOMMENDATION, ELECTRONIC DEVICE AND COMPUTER-READABLE STORAGE MEDIUMDecember 2020February 2026Abandon6040NoNo
17095299METHOD AND A SYSTEM FOR EVALUATING TREATMENT STRATEGIES ON A VIRTUAL MODEL OF A PATIENTNovember 2020May 2025Abandon5440NoNo
17092431METHOD FOR DETERMINING EFFECT FOR AN INDIVIDUAL PATIENTNovember 2020February 2025Abandon5130YesNo
17003736SYSTEMS AND METHODS FOR OFFERING PRODUCTS BASED ON MEDICAL ASSESSMENTSAugust 2020June 2024Allow4631YesNo
17001436SYSTEMS AND METHODS FOR GENERATING DATA QUALITY INDICES FOR PATIENTSAugust 2020July 2025Abandon5960YesNo
16984118SYSTEMS FOR MANAGING BIOPSY SPECIMENSAugust 2020June 2024Allow4640YesNo
16870700JOINT GIFT REGISTRYMay 2020September 2025Abandon6021NoYes
16754399ANALYZING CLINICAL PATHWAYSApril 2020October 2024Abandon5560NoNo
16652878METHODS AND SYSTEMS FOR HEALTHCARE CLINICAL TRIALSApril 2020April 2025Abandon6060NoNo
16538115PATIENT-BASED DIETARY PLAN RECOMMENDATION SYSTEMAugust 2019July 2025Abandon6080YesYes
16466673TUMOR TRACKING WITH INTELLIGENT TUMOR SIZE CHANGE NOTICEJune 2019September 2025Abandon6050NoYes
15319270CONTINUOUS MONITORING OF EVENT TRAJECTORIES SYSTEM AND RELATED METHODDecember 2016October 2025Abandon6080NoYes
15131738Healthcare Information System With Clinical Information ExchangeApril 2016September 2018Allow2940NoYes
13933100ROUTE NAVIGATION FOR OPTIMAL MOBILE COVERAGEJuly 2013January 2015Allow1920YesNo
12641644METHOD AND APPARATUS FOR PROCESSING PHARMACEUTICAL ORDERS TO DETERMINE WHETHER A BUYER OF PHARMACEUTICALS QUALIFIES FOR AN "OWN USE" DISCOUNTDecember 2009October 2011Allow2220NoNo
12537519ONLINE METHOD AND SYSTEM FOR FULFILLING NEEDS RESULTING FROM PROPERTY AND OTHER SIMILAR LOSSESAugust 2009October 2011Allow2600YesNo
12342644PROCESS OF INTERFACING A PATIENT INDIRECTLY WITH THEIR OWN ELECTRONIC MEDICAL RECORDSDecember 2008February 2011Allow2610YesNo
11929472DISEASE MANAGEMENT SYSTEM AND METHOD INCLUDING PERMISSION DATABASEOctober 2007December 2013Allow6041NoNo
11769553METHOD AND APPARATUS FOR IMPROVING THE LOSS RATIO ON AN INSURANCE PROGRAM BOOKJune 2007September 2010Allow3900NoNo
11423881METHODS AND APPARATUS FOR INCREASING AND/OR FOR MONITORING A PARTY'S COMPLIANCE WITH A SCHEDULE FOR TAKING MEDICINESJune 2006May 2011Allow5932YesNo
11444082SYSTEM FOR PROVIDING EXPERT CARE TO A BASIC CARE MEDICAL FACILITY FROM A REMOTE LOCATIONMay 2006September 2009Allow4000NoNo
11315054CLIENT DRIVEN HEALTHCARE SYSTEM AND PROCESSDecember 2005December 2008Allow3630YesNo
10939037METHOD AND SYSTEM FOR PROVIDING A USER-SELECTED HEALTHCARE SERVICES PACKAGE AND HEALTHCARE SERVICES PANEL CUSTOMIZED BASED ON A USER'S SELECTIONSSeptember 2004March 2009Abandon5551NoYes
10922302METHOD AND SYSTEM FOR DISPENSING, TRACKING AND MANAGING PHARMACEUTICAL PRODUCTSAugust 2004March 2010Allow6010NoNo
10808810METHOD AND SYSTEM FOR PROVIDING A USER-SELECTED HEALTHCARE SERVICES PACKAGE AND HEALTHCARE SERVICES PANEL CUSTOMIZED BASED ON A USER'S SELECTIONSMarch 2004June 2010Allow6030YesNo
10463125METHOD AND SYSTEM FOR INSURING CLUB MEMBERSHIP FEESJune 2003December 2009Allow6041YesNo
10395400PERSONAL BUSINESS SERVICE SYSTEM AND METHODMarch 2003April 2013Allow6080NoYes
10290725SYSTEM AND PROCESS FOR MATCHING PATIENTS WITH CLINICAL MEDICAL TRIALSNovember 2002April 2008Allow6030NoNo
09941682PRESCRIPTION MANAGEMENT SYSTEMAugust 2001March 2009Allow6050YesNo
09865696METHOD FOR MONITORING RADIOLOGY MACHINES, OPERATORS AND EXAMINATIONSMay 2001September 2010Allow6060YesYes
09681413REINSURANCE AUCTION PROCESSMarch 2001October 2008Allow6041YesYes
09798182METHODS AND SYSTEMS FOR INSURING AN ENTITY'S EXPOSURE TO LIABILITYMarch 2001January 2008Allow6031YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PORTER, RACHEL L.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
3
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
17.9%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
4
(40.0%)
Not Allowed After Appeal Filing
6
(60.0%)
Filing Benefit Percentile
67.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner PORTER, RACHEL L - Prosecution Strategy Guide

Executive Summary

Examiner PORTER, RACHEL L works in Art Unit 3684 and has examined 51 patent applications in our dataset. With an allowance rate of 45.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.

Allowance Patterns

Examiner PORTER, RACHEL L's allowance rate of 45.1% places them in the 9% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by PORTER, RACHEL L receive 3.45 office actions before reaching final disposition. This places the examiner in the 93% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PORTER, RACHEL L is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +29.2% benefit to allowance rate for applications examined by PORTER, RACHEL L. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.5% of applications are subsequently allowed. This success rate is in the 10% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 11.1% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 62.5% of appeals filed. This is in the 41% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 38.5% are granted (fully or in part). This grant rate is in the 27% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 21.6% of allowed cases (in the 98% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.